Ribostamycin sulfate cas no:53797-35-6
Synonyms: Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-2-deoxy-, sulfate;(2R,3R,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol; sulfuric acid;Vistamycin (TN);Ribomycine;5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[(2S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol; sulfuric acid;SF 733 antibioic sulfate;Ribostamin;(2R,3R,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol sulfate;Ribostamycin sulfate salt;Prestwick_190;Ribostamycin sulfate (JP14);Ribostamycin sulphate;Riboflavine sulfate;Landamycine;GA4+7;
NameRibostamycin sulfate
CAS53797-35-6
SynonymsStreptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-2-deoxy-, sulfate;(2R,3R,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol; sulfuric acid;Vistamycin (TN);Ribomycine;5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[(2S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol; sulfuric acid;SF 733 antibioic sulfate;Ribostamin;(2R,3R,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol sulfate;Ribostamycin sulfate salt;Prestwick_190;Ribostamycin sulfate (JP14);Ribostamycin sulphate;Riboflavine sulfate;Landamycine;GA4+7;
EINECS(EC#)258-783-1
Molecular FormulaC17H34N4O10.H2SO4
Molecular Weight552.55
AppearanceCOA
storage temp2-8°C
Hazard T,Xi
Risk R61
Safety
Poison by intravenous route. Moderately toxic by intraperitoneal, intramuscular, and subcutaneous routes. Used as an antibiotic. When heated to decomposition it emits very toxic fumes of NOx and SOx.
Hazard Codes: T
,Xi.gif)
Risk Statements:
20: Harmful by inhalation
21: Harmful in contact with skin
22: Harmful if swallowed
36: Irritating to the eyes
38: Irritating to the skin
61: May cause harm to the unborn child
Safety Statements:
22: Do not breathe dust
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36: Wear suitable protective clothing
37: Wear suitable gloves
39: Wear eye/face protection
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
53: Avoid exposure - obtain special instruction before use
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intramuscular |
1561mg/kg (1561mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. |
mouse |
LD50 |
intraperitoneal |
1981mg/kg (1981mg/kg) |
|
Japan Medical Gazette. Vol. 10(2), Pg. 5, 1973. |
mouse |
LD50 |
intravenous |
210mg/kg (210mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. |
mouse |
LD50 |
oral |
> 7gm/kg (7000mg/kg) |
|
Drugs in Japan Vol. 6, Pg. 885, 1982. |
mouse |
LD50 |
subcutaneous |
2345mg/kg (2345mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. |
rat |
LD50 |
intramuscular |
2030mg/kg (2030mg/kg) |
|
Drugs in Japan Vol. 6, Pg. 885, 1982. |
rat |
LD50 |
intraperitoneal |
3080mg/kg (3080mg/kg) |
|
Japan Medical Gazette. Vol. 10(2), Pg. 5, 1973. |
rat |
LD50 |
intravenous |
375mg/kg (375mg/kg) |
|
Japan Medical Gazette. Vol. 10(2), Pg. 5, 1973. |
rat |
LD50 |
oral |
> 7gm/kg (7000mg/kg) |
|
Drugs in Japan Vol. 6, Pg. 885, 1982. |
rat |
LD50 |
subcutaneous |
5600mg/kg (5600mg/kg) |
|
Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 90, 1973. |